Skip to content

A Cadaveric and Radiologic Study of Sacral Erector Spinae Plane Block (ESPB)

Comparison of Median, Intermediate and Lateral Approach to Sacral Erector Spinae Plane Block: a Cadaveric and Radiologic Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05716061
Acronym
ESPB
Enrollment
4
Registered
2023-02-08
Start date
2023-02-17
Completion date
2023-03-18
Last updated
2023-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nerve Block

Keywords

cadaver study, erector spinae plane block, anatomic dissection

Brief summary

The goal of this cadaveric study is to learn about the distribution of contrast agent in ultrasound-guided sacral ESPB. The main questions it aims to answer are 1. Which nerves are affected by this block. 2. Which approach is the best for optimal analgesia in human

Detailed description

4 embalmed cadavers will be divided into groups of 2 and sacral ESPB will be made with 2 different methods. The cadavers will be removed from the solution 48 hours before and will be placed in the prone position, there will be no history of trauma or surgery in the sacral region of the cadavers, and no dissection will be performed from the sacral regions. In the median approach, the probe will be placed on the cadaver, which was previously placed in the prone position, using a 12-18 megahertz high-frequency linear probe with ultrasound to form a right angle to the sacral crest. After being placed parallel to the sacrum and observing the median crest, a 50 mm echogenic needle will be inserted by advancing the implant towards the second sacral level. After touching the crest, the distribution will be observed by retreating 1mm and making 1 cc of serum physiologic. Then all 40 ml of methylene blue and radiocontrast solution will be given. In the intermediate approach; From the second sacral level, 20 ml of red acrylic dye and a solution containing radiocontrast will be given to the right and left by entering the sulcus between the median and intermedian crests with the same technique, using the same technique, under the guidance of ultrasound. After the procedure, sacral tomography will be performed on the cadavers. The spread of radiocontrast material will be observed and their reconstruction will be performed. Later, anatomical dissection will be performed on the cadavers and the spread of the dyes given will be observed. Which of the sacral intervention methods is more effective in clinical practice will be evaluated. Estimated durations of the study; 1. Removing the cadavers from the solution 48 hours before, performing the block, going to the radiology and performing the CT scan, coming to the anatomy laboratory and performing the dissection: 3 days 2. Reconstruction and interpretation of radiology images: 1 week 3. Interpretation of anatomical dissection: 1 week 4. Evaluation and writing of the study: 1 month

Interventions

PROCEDURESacral ESPB

Cadaver study

Sponsors

Karadeniz Technical University
CollaboratorOTHER
Ankara University
CollaboratorOTHER
Giresun University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Embalmed cadaver

Exclusion criteria

* None of the cadavers had a history of trauma or surgery in the sacral region

Design outcomes

Primary

MeasureTime frameDescription
Completion of blocks for 4 cadavers3 daysUltrasound guided sacral ESPB will be performed on 4 cadavers in 2 different approaches
Completion of computed tomography of 4 cadavers3 dayComputed tomography will be taken in 4 cadavers to observe the distribution of the radiocontrast material given to 2 different regions.

Secondary

MeasureTime frameDescription
Completion of dissection of 4 cadavers3 daysFour cadaveric specimens will be dissected in order to detect dye spread through tissue compartments

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026